KCN will get back to paying a chunky dividend (and buyback) in 2024.
They really are one of the few goldies that have and high and consistent payout ratio when producing.
They also kept it to a relatively small number of shares, so not diluted to hell during the shutdown fiasco.
EMR is a good measure of where we will get to quickly. EMR produce the same 110k annual, but a slightly lower AISC. Not sure of their royalty or tax holiday status in Cambodia. EMR have a current market cap of $1.5B and KCN is $275M.
Unlike other startups, KCN has a great track record of regular production out of Thailand.
I believe KCN jave set a very low bar on production and AISC. This makes for a lower valuation now, but there is upside to shareholders when they start to shoot the lights out.
Buying as much as I can, as I expect a 20-30c dividend and buyback soon, so keeping this stock for a very long-term cash cow.
The only risk is an opportunistic takeover. EMR has the cash and is working in a bordering country - so I would make a tilt if I were them!
KCN will get back to paying a chunky dividend (and buyback) in...
Add KCN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
-0.035(2.81%) |
Mkt cap ! $311.8M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.27 | $1.21 | $9.496M | 7.813M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 158372 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.23 | 442307 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| KCN (ASX) Chart |